“Frontline DNA-Repair Inhibition As Maintenance in High-Risk Ovarian Carcinoma”. International Journal of Clinical Research and Medical Sciences 1, no. 3 (October 23, 2026). Accessed November 8, 2026. https://journals.femington.com/ijcrms/article/view/18.